However, later studies implicated that miR-519d also targeted several tumor suppressors, including CDKN1A/p21, PTEN and TIMP2, and thus potentially exerted oncogenic property in hepatocellular carcinoma development [15]. The gene discussed is CDKN1A; the disease is hepatocellular carcinoma.